Antifungal drugs during pregnancy: an updated review

被引:90
作者
Pilmis, Benoit [1 ]
Jullien, Vincent [2 ]
Sobel, Jack [3 ]
Lecuit, Marc [1 ]
Lortholary, Olivier [1 ]
Charlier, Caroline [1 ]
机构
[1] Univ Paris 05, Sorbonne Paris Cite, Hop Necker Enfants Malad, Infect Dis Dept,Ctr Infectiol Necker Pasteur, Paris, France
[2] Univ Paris 05, Dept Pharmacol, Hop Europeen Georges Pompidou, Sorbonne Paris Cite,Inserm,U1229, Paris, France
[3] Wayne State Univ, Detroit, MI USA
关键词
fetus; placenta; antifungal therapy; fungal infections; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES-SOCIETY; VISCERAL LEISHMANIASIS; AMPHOTERICIN-B; DISSEMINATED BLASTOMYCOSIS; CONGENITAL-MALFORMATIONS; PROSPECTIVE COHORT; ORAL FLUCONAZOLE; BIRTH-DEFECTS; CASE SERIES;
D O I
10.1093/jac/dku355
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antifungal prescription remains a challenge in pregnant women because of uncertainties regarding fetal toxicity and altered maternal pharmacokinetic parameters that may affect efficacy or increase maternal and fetal toxicity. We present updated data reviewing the available knowledge and current recommendations regarding antifungal prescription in pregnancy. Amphotericin B remains the first-choice parenteral drug in spite of its well-established toxicity. Topical drugs are used throughout pregnancy because of limited absorption. Recent data have clarified the teratogenic effect of high-dose fluconazole during the first trimester and provided reassuring cumulative data regarding its use at a single low dose in this key period. Recent data have also provided additional safety data on itraconazole and lipidic derivatives of amphotericin B. Regarding newer antifungal drugs, including posaconazole and echinocandins, clinical data are critically needed before considering prescription in pregnancy.
引用
收藏
页码:14 / 22
页数:9
相关论文
共 80 条
[51]   Guideline vulvovaginal candidosis (2010) of the german society for gynecology and obstetrics, the working group for infections and infectimmunology in gynecology and obstetrics, the german society of dermatology, the board of german dermatologists and the german speaking mycological society [J].
Mendling, W. ;
Brasch, J. .
MYCOSES, 2012, 55 :1-13
[52]   Pathogenic pathways in fluconazole-induced branchial arch malformations [J].
Menegola, E ;
Broccia, ML ;
Di Renzo, F ;
Giavini, E .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2003, 67 (02) :116-124
[53]   Use of Oral Fluconazole during Pregnancy and the Risk of Birth Defects [J].
Molgaard-Nielsen, Ditte ;
Pasternak, Bjoern ;
Hviid, Anders .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) :830-839
[54]  
Moudgal Varsha V, 2003, Expert Opin Drug Saf, V2, P475, DOI 10.1517/14740338.2.5.475
[55]   A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan [J].
Mueller, Marius ;
Balasegaram, Manica ;
Koummuki, Youssif ;
Ritmeijer, Koert ;
Santana, Muriel Ramirez ;
Davidson, Robert .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (04) :811-815
[56]   Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study [J].
Norgaard, Mette ;
Pedersen, Lars ;
Gislum, Mette ;
Erichsen, Rune ;
Sogaard, Kirstine Kobberoe ;
Schonheyder, Henrik Carl ;
Sorensen, Henrik Toft .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (01) :172-176
[57]  
Nutley N, 2003, ANCOBON PACKAGE INSE
[58]   Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature [J].
Pagliano, P ;
Carannante, N ;
Rossi, M ;
Gramiccia, M ;
Gradoni, L ;
Faella, FS ;
Gaeta, GB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (02) :229-233
[59]   Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America [J].
Pappas, Peter G. ;
Kauffman, Carol A. ;
Andes, David ;
Benjamin, Daniel K., Jr. ;
Calandra, Thierry F. ;
Edwards, John E., Jr. ;
Filler, Scott G. ;
Fisher, John F. ;
Kullberg, Bart-Jan ;
Ostrosky-Zeichner, Luis ;
Reboli, Annette C. ;
Rex, John H. ;
Walsh, Thomas J. ;
Sobel, Jack D. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (05) :503-535
[60]   Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America [J].
Perfect, John R. ;
Dismukes, William E. ;
Dromer, Francoise ;
Goldman, David L. ;
Graybill, John R. ;
Hamill, Richard J. ;
Harrison, Thomas S. ;
Larsen, Robert A. ;
Lortholary, Olivier ;
Nguyen, Minh-Hong ;
Pappas, Peter G. ;
Powderly, William G. ;
Singh, Nina ;
Sobel, Jack D. ;
Sorrell, Tania C. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (03) :291-322